Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LUCENTIS: 686 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
686
Total FAERS Reports
184 (26.8%)
Deaths Reported
180
Hospitalizations
686
As Primary/Secondary Suspect
15
Life-Threatening
23
Disabilities

First Report: 20061002 · Latest Report: 20140526

What Are the Most Common LUCENTIS Side Effects?

#1 Most Reported
Death
138 reports (20.1%)
#2 Most Reported
Visual acuity reduced
98 reports (14.3%)
#3 Most Reported
Vision blurred
64 reports (9.3%)

All LUCENTIS Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Death 138 20.1% 138 2
Visual acuity reduced 98 14.3% 2 20
Vision blurred 64 9.3% 2 14
Cerebrovascular accident 54 7.9% 6 27
Off label use 54 7.9% 2 8
Eye pain 43 6.3% 1 3
Visual impairment 43 6.3% 4 10
Vitreous floaters 42 6.1% 2 11
Blindness 34 5.0% 1 1
Drug ineffective 33 4.8% 0 3
Myocardial infarction 33 4.8% 8 16
Cataract 27 3.9% 0 6
Macular oedema 26 3.8% 0 3
Retinal haemorrhage 26 3.8% 0 8
Cataract nuclear 20 2.9% 0 5
Eye haemorrhage 19 2.8% 1 3
Vitreous detachment 19 2.8% 0 4
Retinal oedema 18 2.6% 0 3
Ocular hyperaemia 17 2.5% 0 1
Retinal detachment 17 2.5% 0 4

Who Reports LUCENTIS Side Effects? Age & Gender Data

Average age: 71.6 years. Most reports from: US. View detailed demographics →

Is LUCENTIS Getting Safer? Reports by Year

YearReportsDeathsHosp.
2006 1 0 0
2007 3 0 0
2008 3 0 1
2009 1 0 1
2010 11 1 0
2011 33 1 7
2012 29 4 14
2013 196 75 73
2014 87 21 43

View full timeline →

What Is LUCENTIS Used For?

IndicationReports
Age-related macular degeneration 248
Product used for unknown indication 191
Diabetic retinal oedema 94
Macular degeneration 51
Retinal vein occlusion 51
Diabetic retinopathy 35
Retinal oedema 17
Choroidal neovascularisation 11
Macular oedema 11
Cystoid macular oedema 10

LUCENTIS vs Alternatives: Which Is Safer?

LUCENTIS vs LUCRIN DEPOT LUCENTIS vs LUMASIRAN LUCENTIS vs LUMATEPERONE LUCENTIS vs LUMIGAN LUCENTIS vs LUPRON DEPOT LUCENTIS vs LUPRON DEPOT-PED LUCENTIS vs LURASIDONE LUCENTIS vs LURBINECTEDIN LUCENTIS vs LUSPATERCEPT LUCENTIS vs LUSPATERCEPT-AAMT

Official FDA Label for LUCENTIS

Official prescribing information from the FDA-approved drug label.